Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Malate acetated Ringer's solution is a balanced crystalloid intravenous fluid used for the replacement of extracellular fluid and the correction of metabolic acidosis. Developed primarily by Otsuka Pharmaceutical (marketed as Physio140), it contains a physiological balance of electrolytes including sodium, potassium, magnesium, calcium, and chloride. Unlike traditional Lactated Ringer's, it uses acetate and malate as buffering agents; these are metabolized into bicarbonate in various tissues (including muscle and liver), providing a more rapid buffering effect and reducing the metabolic burden on the liver. It is indicated for fluid resuscitation in patients with trauma, surgery, or severe dehydration where acid-base balance must be maintained.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on malate acetated ringer's solution.